Chronic Lead Exposure in Nuclear Medicine

Samantha Stevenson, Geoffrey Currie, Janelle Wheat

Research output: Contribution to journalArticle

10 Downloads (Pure)

Abstract

Introduction: Lead has been used as a means of radiation shielding in the Nuclear Medicine since the profession emerged (Christian et al, 2007; Thrall, O'Malley, & Ziessman, 2006). Today, lead is used in products ranging from collimators and structural walls to that of simple lead syringe shields and carry pots (Christian et al, 2007; Holden, 2008). While the less malleable properties of tungsten has seen it replace the use of lead in many products, the lower cost of lead has ensured widespread use remains. Despite a long history of widespread use of lead, there is a paucity of information relating to health implications of such generalised exposure in Nuclear Medicine. The detrimental health effects of lead have been well documented (Herman & Geraldine, 2007; Khan, 2009; Landrigan et al, 1994). Both chronic and acute forms of lead exposure affect numerous organ systems, producing long term irreversible conditions such as cognitive deterioration, renal failure and sterility (Herman & Geraldine, 2007; Khan, 2009; Marcus, 2007). Although workplace exposure within areas of lead production such as smelting and battery production are well documented, knowledge of the degree of exposure to allied health workers is poor (Cunningham, 2007; Roscoe et al, Dec 2002; Saito et al, 2006). The chronic exposure rate to lead of Nuclear Medicine workers is unknown (Bellinger, 2004; Khan, 2009; Parsons & Chisolm, 1999).
Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalInternet Journal of Nuclear Medicine
Volume5
Issue number1
Publication statusPublished - 2008

Fingerprint

Medicine
Health effects
Work place
Health workers
Workers
Deterioration
Radiation
Costs
Health

Cite this

@article{9d63b3debb3c4876a715e494568c6b6a,
title = "Chronic Lead Exposure in Nuclear Medicine",
abstract = "Introduction: Lead has been used as a means of radiation shielding in the Nuclear Medicine since the profession emerged (Christian et al, 2007; Thrall, O'Malley, & Ziessman, 2006). Today, lead is used in products ranging from collimators and structural walls to that of simple lead syringe shields and carry pots (Christian et al, 2007; Holden, 2008). While the less malleable properties of tungsten has seen it replace the use of lead in many products, the lower cost of lead has ensured widespread use remains. Despite a long history of widespread use of lead, there is a paucity of information relating to health implications of such generalised exposure in Nuclear Medicine. The detrimental health effects of lead have been well documented (Herman & Geraldine, 2007; Khan, 2009; Landrigan et al, 1994). Both chronic and acute forms of lead exposure affect numerous organ systems, producing long term irreversible conditions such as cognitive deterioration, renal failure and sterility (Herman & Geraldine, 2007; Khan, 2009; Marcus, 2007). Although workplace exposure within areas of lead production such as smelting and battery production are well documented, knowledge of the degree of exposure to allied health workers is poor (Cunningham, 2007; Roscoe et al, Dec 2002; Saito et al, 2006). The chronic exposure rate to lead of Nuclear Medicine workers is unknown (Bellinger, 2004; Khan, 2009; Parsons & Chisolm, 1999).",
keywords = "Open access version available, Contamination, Lead, Nuclear medicine, Occupational hazard",
author = "Samantha Stevenson and Geoffrey Currie and Janelle Wheat",
note = "Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = The Internet Journal of Nuclear Medicine. ISSNs: 1539-4638;",
year = "2008",
language = "English",
volume = "5",
pages = "1--5",
journal = "Internet Journal of Nuclear Medicine",
issn = "1539-4638",
number = "1",

}

Chronic Lead Exposure in Nuclear Medicine. / Stevenson, Samantha; Currie, Geoffrey; Wheat, Janelle.

In: Internet Journal of Nuclear Medicine, Vol. 5, No. 1, 2008, p. 1-5.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chronic Lead Exposure in Nuclear Medicine

AU - Stevenson, Samantha

AU - Currie, Geoffrey

AU - Wheat, Janelle

N1 - Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = The Internet Journal of Nuclear Medicine. ISSNs: 1539-4638;

PY - 2008

Y1 - 2008

N2 - Introduction: Lead has been used as a means of radiation shielding in the Nuclear Medicine since the profession emerged (Christian et al, 2007; Thrall, O'Malley, & Ziessman, 2006). Today, lead is used in products ranging from collimators and structural walls to that of simple lead syringe shields and carry pots (Christian et al, 2007; Holden, 2008). While the less malleable properties of tungsten has seen it replace the use of lead in many products, the lower cost of lead has ensured widespread use remains. Despite a long history of widespread use of lead, there is a paucity of information relating to health implications of such generalised exposure in Nuclear Medicine. The detrimental health effects of lead have been well documented (Herman & Geraldine, 2007; Khan, 2009; Landrigan et al, 1994). Both chronic and acute forms of lead exposure affect numerous organ systems, producing long term irreversible conditions such as cognitive deterioration, renal failure and sterility (Herman & Geraldine, 2007; Khan, 2009; Marcus, 2007). Although workplace exposure within areas of lead production such as smelting and battery production are well documented, knowledge of the degree of exposure to allied health workers is poor (Cunningham, 2007; Roscoe et al, Dec 2002; Saito et al, 2006). The chronic exposure rate to lead of Nuclear Medicine workers is unknown (Bellinger, 2004; Khan, 2009; Parsons & Chisolm, 1999).

AB - Introduction: Lead has been used as a means of radiation shielding in the Nuclear Medicine since the profession emerged (Christian et al, 2007; Thrall, O'Malley, & Ziessman, 2006). Today, lead is used in products ranging from collimators and structural walls to that of simple lead syringe shields and carry pots (Christian et al, 2007; Holden, 2008). While the less malleable properties of tungsten has seen it replace the use of lead in many products, the lower cost of lead has ensured widespread use remains. Despite a long history of widespread use of lead, there is a paucity of information relating to health implications of such generalised exposure in Nuclear Medicine. The detrimental health effects of lead have been well documented (Herman & Geraldine, 2007; Khan, 2009; Landrigan et al, 1994). Both chronic and acute forms of lead exposure affect numerous organ systems, producing long term irreversible conditions such as cognitive deterioration, renal failure and sterility (Herman & Geraldine, 2007; Khan, 2009; Marcus, 2007). Although workplace exposure within areas of lead production such as smelting and battery production are well documented, knowledge of the degree of exposure to allied health workers is poor (Cunningham, 2007; Roscoe et al, Dec 2002; Saito et al, 2006). The chronic exposure rate to lead of Nuclear Medicine workers is unknown (Bellinger, 2004; Khan, 2009; Parsons & Chisolm, 1999).

KW - Open access version available

KW - Contamination

KW - Lead

KW - Nuclear medicine

KW - Occupational hazard

M3 - Article

VL - 5

SP - 1

EP - 5

JO - Internet Journal of Nuclear Medicine

JF - Internet Journal of Nuclear Medicine

SN - 1539-4638

IS - 1

ER -